Corrigendum: Low Dose Radiation Therapy Induces Long-Lasting Reduction of Pain and Immune Modulations in the Peripheral Blood - Interim Analysis of the IMMO-LDRT01 Trial(Front. Immunol., (2021), 12, (740742), 10.3389/fimmu.2021.740742)

Donaubauer AJ, Becker I, Weissmann T, Fröhlich B, Munoz LE, Gryc T, Denzler M, Ott O, Fietkau R, Gaipl U, Frey B (2022)

Publication Type: Journal article, Erratum

Publication year: 2022

Journal

Frontiers in Immunology Frontiers Research Foundation / Frontiers Media

Book Volume: 13

Article Number: 859489

DOI: 10.3389/fimmu.2022.859489

Abstract

In the original article, there was an error. The mistake is found in the sentence “While the total number of leukocytes remained unchanged in the peripheral blood, LDRT induced a slight reduction of eosinophils, basophils and plasmacytoid dendritic cells and an increase of B cells.” in the abstract of the article.

Authors with CRIS profile

Anna-Jasmina Donaubauer Department of Radiation Oncology Ina Becker Department of Radiation Oncology Thomas Weissmann Department of Radiation Oncology Birgitta Fröhlich Department of Radiation Oncology Luis Munoz Becerra Department of Medicine 3 – Rheumatology and Immunology Thomas Gryc Department of Radiation Oncology Oliver Ott Medizinische Fakultät Rainer Fietkau Lehrstuhl für Strahlentherapie Udo Gaipl Department of Radiation Oncology Benjamin Frey Department of Radiation Oncology

How to cite

APA:

Donaubauer, A.-J., Becker, I., Weissmann, T., Fröhlich, B., Munoz, L.E., Gryc, T.,... Frey, B. (2022). Corrigendum: Low Dose Radiation Therapy Induces Long-Lasting Reduction of Pain and Immune Modulations in the Peripheral Blood - Interim Analysis of the IMMO-LDRT01 Trial(Front. Immunol., (2021), 12, (740742), 10.3389/fimmu.2021.740742). Frontiers in Immunology, 13. https://doi.org/10.3389/fimmu.2022.859489

MLA:

Donaubauer, Anna-Jasmina, et al. "Corrigendum: Low Dose Radiation Therapy Induces Long-Lasting Reduction of Pain and Immune Modulations in the Peripheral Blood - Interim Analysis of the IMMO-LDRT01 Trial(Front. Immunol., (2021), 12, (740742), 10.3389/fimmu.2021.740742)." Frontiers in Immunology 13 (2022).

BibTeX: Download